Human Genome Sciences Announces Second-Quarter 2009 Financial Results and Key Developments

... (HHS). In May 2009, HGS submitted a biologics License Application (BLA) to the FDA for ... 2009. In May 2009, HGS submitted a biologics License Application to the FDA for raxibacumab ... risks related to FDA's approval of the Company's biologics License Application for raxibacumab. If the ...

Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharmacy Benefit

... and single state plans say coverage of immune biologics will shift from a medical benefit to a pharmacy ... as a pharmacy benefit, but cover other immune biologics as a medical benefit. The report finds that payers expect the shift of biologics from the medical benefit to the pharmacy benefit ...

CMPI to Host Hill Briefing Tomorrow on Follow-on Biologic Drugs for Media and Congressional Staff With Reps. Eshoo and Rogers

... and Congressional Staff entitled: "A Follow-on biologics Legislation Update; Congressional Leaders and ... patient safety is the top-priority for follow-on biologics legislation," said Robert Goldberg of CMPI. "The ... that advocates for safe and effective follow-on biologics do all they can to support Representative Eshoo's ...

China's Rheumatoid Arthritis Drug Market Will More than Double by 2013

... uptake of currently available Western branded biologics and the launch of new biologics. The best ... Chinese generic versions of new Western branded biologics than for small-molecule drugs for two reasons: biologics are harder to imitate than small chemical ...

CMPI to Host Hill Briefing on Follow-On Biologic Drugs for Media and Congressional Staff with Reps. Eshoo and Rogers

... and Congressional Staff entitled: "A Follow-On biologics Legislation Update; Congressional Leaders and ... patient safety is the top-priority for follow-on biologics legislation," said Robert Goldberg of CMPI. "The ... that advocates for safe and effective follow-on biologics do all they can to support Representative Eshoo's ...

Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics

... and license agreement with MedImmune, the global biologics unit of AstraZeneca plc, to develop novel ... therapeutics are next-generation, protease biologics engineered with the ability to catalytically ... About MedImmune MedImmune, the worldwide biologics business for AstraZeneca PLC (LSE: AZN.L, NYSE: ...

Global Autoimmune Disease Therapeutics Market to Reach $50 Billion by 2015, According to a New Report by Global Industry Analysts

... is projected to reach US$49.8 billion in 2015. biologics emerged as the leading therapeutic option in the ... enhanced penetration of existing drugs. Access to biologics in the world's largest drug market, the US, is ... represents the fastest growing segment for biologics in the global autoimmune disease therapeutics ...

CEL-SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annual Aseptic Processing of Sterile Drug Products Conference

... to save money in the production of follow-on biologics and biosimilars (the general equivalent of ... Herceptin, Copaxon, etc.) are biologics. biologics are usually very sensitive to heat and quickly ... to companies that produce the latest drugs, biologics and stem cell derived therapies. It is an ...

American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications

... and psoriatic arthritis, as well as the use of biologics and topical therapies. "While in recent years biologics have changed the treatment of psoriasis, ... administered orally and less expensive than biologics - continue to play an important role in treating ...

Fate Therapeutics Adds Pratik Multani, M.D., M.S., as Vice President Clinical Development to Advance Upcoming Clinical Programs of Stem Cell Modulators

... Stem Cell Modulators (SCMs), small molecules and biologics that guide cell fate for therapeutic purposes. ... led to the identification of small molecules and biologics that can direct stem cell proliferation and ... and unique approach of using small molecules and biologics in stem cell medicine provides a well-defined ...

For the Treatment of Rheumatoid Arthritis, Market Share for TNF-alpha Inhibitors Will Decrease Through 2018

... Rheumatoid Arthritis finds that alternative biologics such as Roche/Chugai's Actemra/RoActemra will ... Pfizer is expected to impact overall sales of biologics in the market. "We expect Pfizer's ... inhibitors, in particular, and constrain the biologics market," said Decision Resources Analyst Joanna ...

Rheumatoid Arthritis Therapeutics in Taiwan

... into the hospital formularies, the usage of biologics would increase for treatment earlier in the ... most cost effective treatment option. Even though biologics are highly effective and recommended for ... to their high cost. Physicians are willing to use biologics if they are listed in the hospital formulary and ...

Rheumatoid Arthritis Therapeutics in China

... into the hospital formularies, the usage of biologics would increase for treatment earlier in the ... most cost effective treatment option. Even though biologics are highly effective and recommended for ... to their high cost. Physicians are willing to use biologics if they are listed in the hospital formulary and ...

Rheumatoid Arthritis Therapeutics in Philippines

... drugs (NSAIDs) as newer medications such as biologics are well beyond the affordability of the ... into the hospital formularies, the usage of biologics would increase for treatment earlier in the disease." Even though biologics are highly effective and recommended for ...

Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia

... into the hospital formularies, the usage of biologics would increase for treatment earlier in the ... most cost effective treatment option. Even though biologics are highly effective and recommended for ... to their high cost. Physicians are willing to use biologics if they are listed in the hospital formulary and ...

Cardium Reports on Recent Highlights, Financial Results and 2009 Outlook

... (e.g., ligament, tendon and cartilage). biologics and Stem Cells for Cardiovascular Disease and ... Cardium has also developed additional biologics for potential application in cardiovascular ... that are inherent in the development of complex biologics and therapeutic hypothermia devices and in the ...

BioTrends Prepares to Field ChartTrends(TM) Reports to Cover the Use of Biologic Agents in Psoriasis and Rheumatoid Arthritis

... Research Group, Inc. has been covering the biologics market for Psoriasis and RA through its ... insight into the management and use of biologics used in the treatment of Rheumatoid Arthritis ... familiarity and interest in several late stage biologics in development (Roche's ACTEMRA, Centocor's ...

Barr's BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA

... Adenovirus Types 4 and 7 Live Oral Vaccines biologics License Application (BLA). These oral vaccines represent Barr's first in-house biologics development initiative and demonstrate the ... have achieved a significant step in building our biologics program," said Bruce L. Downey, Barr's Chairman ...

Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs

... Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals, today announced that ... market trends, our entrance into the follow on biologics market may be unsuccessful, we may be unable to ... appropriate business partner for our follow-on biologics business, our common stock could be delisted from ...

RTI Biologics Sees Expanded Surgeon User Base of Fresh OC Allografts

... specialist at (800) 624-7238. About RTI biologics Inc. RTI Biologics, Inc. is the leading ... raise the bar of science and safety for biologics — from being the first company to offer ... The company is leading the evolution of biologics once again by offering a bovine based biological ...

Humira to Replace Remicade as First Choice Among Biologics for the Treatment of Crohn's Disease

... physicians are increasingly moving patients to biologics early in treatment. "Moving up in lines of ... Ph.D., analyst at Decision Resources. "Because biologics are much more expensive than conventional agents, ... welcome to attend our upcoming webinar entitled biologics Penetration of Early Lines of Therapy in ...

After Fits and Starts, New Hope for Psoriasis Patients

... Doctors tout drugs called biologics during Psoriasis Awareness Month ... many as 7.5 million Americans have psoriasis. biologics are made from human or animal proteins, and they ... extra inflammatory compounds." Currently, five biologics are approved by the U.S. Food and Drug ...

WuXi PharmaTech Announces Second Quarter 2008 Results

... development; potential near-term lumpiness in our biologics business due to smaller clients issues with their ... large pharmaceutical customer interest in biologics testing and manufacturing services in China--a ... business and R&D outsourcing trends; our smaller biologics clients may continue to face cell ...

Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugai's Actemra for Rheumatoid Arthritis

... The new Physician & Payer Forum report, biologics in Rheumatoid Arthritis: Physician and Payer Perspective on Recently Launched and Emerging biologics in Rheumatoid Arthritis, finds that ... before moving to a different class of agents." biologics in Rheumatoid Arthritis: Physician and Payer ...

Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion

... has also built up an impressive track record in biologics manufacturing. Within less than two years, ... their decisions to site a total of five major biologics manufacturing facilities amounting to US$1.5 ... a conducive environment for pharmaceutical and biologics manufacturing. TBP is currently home to leading ...

Dermatologists Release Psoriasis Care Guidelines

... FRIDAY, May 30 (HealthDay News) -- The use of biologics is the focus of new guidelines for the management ... by the American Academy of Dermatology (ADA). biologics -- given by injection or infusion -- are systemic ... phototherapy treatments. Currently, five biologics are approved by the U.S. Food and Drug ...

Pennsylvania Health Plans Employ Various Strategies to Combat Cost of Specialty Drugs

... use of specialty pharmacies and shifting more biologics from the medical to the pharmacy side of the ... usually reserved for non-preferred brands, with biologics users paying the highest copay. Independence Blue Cross spends $400 million a year on biologics out of a total drug budget of about $1.5 billion. ...

Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine

... use vaccine antigen developed by UK-based Avecia biologics Ltd., applying Iomai's technology in an effort to ... and manufacture of biopharmaceuticals (Avecia biologics Ltd.) and oligonucleotide medicines (Avecia Biotechnology Inc.). Avecia biologics has specific expertise in the invention and ...

MedImmune Expands Scientific and Engineering Leadership

... the solidification of its role as the global biologics unit for AstraZeneca plc (AZ), MedImmune today ... organization into AZ's new global biologics unit, functioning under the name MedImmune. "As ... and met the resourcing needs of the plan for biologics growth. Mr. Boulding holds a bachelor's degree in ...

Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG

... has completed the sale of assets constituting its biologics strategic business unit (SBU) to Biotest ... Biotest has acquired or will acquire the biologics SBU's products, including Nabi- HB(R) and other ... arising from post-closing conduct of the biologics SBU. "The completion of this transaction marks ...

Drug Combos Effective Against Rheumatoid Arthritis

... found that methotrexate was as effective as the biologics adalimumab and etanercept in early rheumatoid ... had better short-term results. However, biologics and methotrexate boost the risk of serious ... not enough evidence to say whether combining two biologics was more effective than using one biologic, ...

Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting

... Approve Sale of Nabi biologics to Biotest BOCA RATON, Fla., Nov. 8 ... held earlier today, the proposal to sell the Nabi biologics strategic business unit and certain ... results, assets and liabilities related to Nabi biologics and certain CSS assets will be reflected as ...

FDA Approves New Flu Vaccine

... U.S. Food and Drug Administration's Center for biologics Evaluation and Research, said during an afternoon ... L. Goodman, M.D., M.P.H., director, Center for biologics Evaluation and Research, U.S. Food and Drug ... of vaccines research and review, Center for biologics Evaluation and Research, U.S. Food and Drug ...

ReGen Biologics Clarifies Recent Press about the Menaflex Device

... safely and effectively. About ReGen Biologics, Inc.: ReGen biologics is an orthopedic products company that develops, manufactures and markets ... countries, and is marketed through ReGen's European subsidiary, ReGen biologics AG. The FDA cleared the Menaflex device to be marketed in the United ...

Bioheart Announces Acceptance of Marvel-1 Data for Presentation at the Heart Failure Society of America (HFSA) Meeting

... Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular ... Bioheart, Inc. is committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular ...

Bioheart to Introduce Improved Heart Failure Monitoring Systems at Heart Failure Nurses Annual Meeting

... Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular ... Inc. Bioheart, Inc. is committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular ...

Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting

... on May 27, 2009. Dr. Barbara K. Sosnowski, Cardium's Vice President of biologics Development and the Chief Operating Officer of Cardium's Tissue Repair ... risks and uncertainties that are inherent in the development of complex biologics and therapeutic hypothermia devices and in the conduct of human clinical ...

BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting

... May 15 /PRNewswire/ -- BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, ... manufacturing facility. The Company is developing a new class of potent biologics for the treatment of cancer and prevention of infectious disease. ...

Hospira Launches Biologics 'Clock' and Web Resource to Raise Awareness of Potential Biogenerics' Impact

... highlighting the potential impact of biogenerics - generic versions of biologics - on the U.S. healthcare system. Although biogenerics are widely available ... in U.S. sales. The Congressional Budget Office (CBO) says spending on biologics has grown in the United States, "exceeding $40 billion" in 2007 (Budget ...

Singapore Adopts Advanced Genetic Engineering in Orthopedic Surgery

... Since mid-2008, the Singapore General Hospital (SGH) has been applying biologics to a highly select group of patients who require spinal fusion for ... less invasive ways to help stabilize the spine. The breakthrough came with biologics - genetically engineered proteins derived from human genes. ...